Download App

Log in to access Online Inquiry
Company Overview More
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing’s syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have failed surgery or are not candidates for surgery. It is developing relacorilant to treat patients with Cushing’s syndrome; and nab-paclitaxel in combination with relacorilant, which has completed Phase II clinical trial to treat patients with advanced ovarian tumors, as well as for the treatment of cortisol excess. The company is also developing selective cortisol modulator to treat patients with metastatic castration-resistant prostate cancer; selective cortisol modulator for the treatment of antipsychotic-induced weight gain and other disorders; and FKBP5 gene expression assays. Corcept Therapeutics Incorporated was incorporated in 1998 and is headquartered in Menlo Park, California.
CEO: Belanoff M.D., Joseph K.
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

CORT Corcept Therapeutics

20.050-0.370-1.81%
Close 05/23 20:00 ET
20.05000.00%
Post Mkt Price 05/23 16:00 ET
High
20.670
Open
20.670
Turnover
12.66M
Low
19.910
Pre Close
20.420
Volume
629.81K
Market Cap
2.13B
P/E(TTM)
22.03
52wk High
25.680
Shares
106.25M
P/E(Static)
22.53
52wk Low
15.825
Float Cap
1.74B
Bid/Ask %
89.19%
Historical High
31.180
Shs Float
86.90M
Volume Ratio
0.72
Historical Low
0.680
Dividend TTM
--
Div Yield TTM
300
P/B
5.22
Dividend LFY
--
Div Yield LFY
1496.26%
Turnover Ratio
0.73%
Amplitude
3.72%
Avg Price
20.108
Lot Size
1
Float Cap
1.74B
Bid/Ask %
89.19%
Historical High
31.180
Shs Float
86.90M
Volume Ratio
0.72
Historical Low
0.680
Dividend TTM
--
P/B
5.22
Dividend LFY
--
Turnover Ratio
0.73%
Amplitude
3.72%
Avg Price
20.108
Lot Size
1
Price Forecast

No Data

News

Comment